W77-20370-50664
4 vaccinations
4 coded responses
35 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Pfizer-BioNTech
- 2021-01-19
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-11
- 2021-03-16
- 2021-03-23
- 2021-05-11
- 2021-08-10
-
2021-08-27
Dose 3 — Pfizer-BioNTech
-
2021-08-28
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body achesFree text: Lymph node swelling and pain in armpitMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: Lymph nodes swollen in arm pitMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-12
- 2021-09-17
- 2021-09-26
- 2021-10-03
- 2021-10-10
- 2021-11-26
- 2022-02-25
-
2022-08-29
Survey response — 12 months, dose 3MedDRA: COVID-19, Headache, Nasopharyngitis, Sinus disorder — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: COVID positive. Cold and sinus symptoms, headache.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-29
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-30
-
2022-09-07
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-02
Survey response — day 21, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: I have a coldMedDRA releases: 2024-11 · check-in free text available
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-12-07
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-08-27 | Pfizer-BioNTech | No |
| 4 | 2022-09-07 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-29 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph node swelling and pain in armpit
Systemic reaction (other): Lymph nodes swollen in arm pit
Release 12 — 12 months, dose 3
Symptoms: COVID positive. Cold and sinus symptoms, headache.
Release 12 — day 21, dose 4
Symptoms: I have a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
| SRO | Axillary pain | ✓ | · | ✓ |
| SRO | Lymphadenopathy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release